249
Pharming Group N.V.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
278
FY23:
316
FY24:
278
FY25:
299
(positive)
Change from FY21 to FY25
millions USD
FY21:
148
FY22:
148
FY23:
147
FY24:
122
FY25:
200
Total assets
Change from FY21 to FY25
millions USD
FY21:
397
FY22:
426
FY23:
463
FY24:
400
FY25:
500
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
46.8
FY22:
59.7
FY23:
78.0
FY24:
73.8
FY25:
116
(negative)
Change from FY22 to FY24
millions USD
FY21:
–
FY22:
161
FY23:
166
FY24:
105
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
193
FY22:
205
FY23:
219
FY24:
221
FY25:
277
Total liabilities & equity
Change from FY22 to FY24
millions USD
FY21:
–
FY22:
426
FY23:
463
FY24:
400
FY25:
–
All amounts in millions USD